The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Open accessAbstract
Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Lewinski, N., Colvin, V., & Drezek, R. (2008) · Small · doi:10.1002/smll.200700595 · Cited by 2,810
On the mechanisms of biocompatibility
Williams, D. F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.023 · Cited by 2,772
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Fotakis, G., & Timbrell, J. A. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.07.001 · Cited by 1,558
The tight junction: a multifunctional complex
Schneeberger, E. E., & Lynch, R. D. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00558.2003 · Cited by 1,409
Chitin and Chitosan: Functional Biopolymers from Marine Crustaceans
Kurita, K. (2006) · Marine Biotechnology · doi:10.1007/s10126-005-0097-5 · Cited by 1,220
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells, J. M., & Roy, N. C. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135657 · Cited by 1,177
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Main properties and current applications of some polysaccharides as biomaterials
Rinaudo, M. (2008) · Polymer International · doi:10.1002/pi.2378 · Cited by 1,028 · cited 2×
“5, chitosan is soluble in acidic solutions owing to the protonation of the amino groups composing the polymeric chain at this pH [13,17].”
BackgroundHuang, M., Khor, E., & Lim, L.-Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016249.52831.a5 · Cited by 853
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Effects of nanomaterial physicochemical properties on in vivo toxicity
Aillon, K. L., Xie, Y., El-Gendy, N., Berkland, C. J., & Forrest, M. L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.010 · Cited by 811
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Recent advances of chitosan nanoparticles as drug carriers
Zeng, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17296 · Cited by 665
Chitosan-based delivery systems for protein therapeutics and antigens
Amidi, M., Mastrobattista, E., Jiskoot, W., & Hennink, W. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.009 · Cited by 620
Monteiro-Riviere, N. A., Inman, A. O., & Zhang, L. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.030 · Cited by 598
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Comparison of alamar blue and MTT assays for high through-put screening
Hamid, R., Rotshteyn, Y., Rabadi, L., Parikh, R., & Bullock, P. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.03.012 · Cited by 570
The safety of chitosan as a pharmaceutical excipient
Baldrick, P. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.09.015 · Cited by 569
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Chitosan Modification and Pharmaceutical/Biomedical Applications
Zhang, J., Xia, W., Liu, P., Cheng, Q., Tahi, T., Gu, W., & Li, B. (2010) · Marine Drugs · doi:10.3390/md8071962 · Cited by 526
A practical note on the use of cytotoxicity assays
Weyermann, J., Lochmann, D., & Zimmer, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.018 · Cited by 525
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Altman, S. A., Randers, L., & Rao, G. (1993) · Biotechnology Progress · doi:10.1021/bp00024a017 · Cited by 399
Borchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
Ren, D., Yi, H., Wang, W., & Ma, X. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.07.022 · Cited by 374
Hastings, G. W. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90031-8 · Cited by 370
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Therapeutic application of peptides and proteins: parenteral forever?
Antosova, Z., Mackova, M., Kral, V., & Macek, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 324
Bernas, T., & Dobrucki, J. (2002) · Cytometry · doi:10.1002/cyto.10080 · Cited by 322
Biocompatibility and drug delivery systems
Kohane, D. S., & Langer, R. (2010) · Chem. Sci. · doi:10.1039/c0sc00203h · Cited by 307
Chitosan nanoparticles: a survey of preparation methods
Grenha, A. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.654121 · Cited by 305
Self-citationGaspar, R., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.003 · Cited by 304
Development of new chitosan/carrageenan nanoparticles for drug delivery applications
Grenha, A., Gomes, M. E., Rodrigues, M., Santo, V. E., Mano, J. F., Neves, N. M., & Reis, R. L. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32466 · Cited by 301
Self-citationLysozyme degradation of partially deacetylated chitin, its films and hydrogels
Pangburn, S. H., Trescony, P. V., & Heller, J. (1982) · Biomaterials · doi:10.1016/0142-9612(82)90043-6 · Cited by 298
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
Sonaje, K., Lin, Y.-H., Juang, J.-H., Wey, S.-P., Chen, C.-T., & Sung, H.-W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.066 · Cited by 295
Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities - a Review
Vinsova, J., & Vavrikova, E. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798194468 · Cited by 294
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Cell Viability Assays: Introduction
Stoddart, M. J. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-108-6_1 · Cited by 270
Validation of an LDH assay for assessing nanoparticle toxicity
Han, X., Gelein, R., Corson, N., Wade-Mercer, P., Jiang, J., Biswas, P., Finkelstein, J. N., Elder, A., & Oberdörster, G. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.011 · Cited by 268
Ma, Z., & Lim, L.-Y. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003379.76417.3e · Cited by 265
Al-Qadi, S., Grenha, A., Carrión-Recio, D., Seijo, B., & Remuñán-López, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.008 · Cited by 265
Self-citationEvaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity
Gonzalez, R. J., & Tarloff, J. B. (2001) · Toxicology in Vitro · doi:10.1016/s0887-2333(01)00014-5 · Cited by 261
Preparation and Solubility in Acid and Water of Partially Deacetylated Chitins
Cho, Y.-W., Jang, J., Park, C. R., & Ko, S.-W. (2000) · Biomacromolecules · doi:10.1021/bm000036j · Cited by 260
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., & Stolnik, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.020 · Cited by 252
N-acetylation in chitosan and the rate of its enzymic hydrolysis
Hirano, S., Tsuchida, H., & Nagao, N. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90066-5 · Cited by 248
Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios
Rodrigues, S., Costa, A. M. R. D., & Grenha, A. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.03.010 · Cited by 246
Self-citationBiomedical Applications of Chitin, Chitosan, and Their Derivatives
SINGH, D. K., & RAY, A. R. (2000) · Journal of Macromolecular Science, Part C: Polymer Reviews · doi:10.1081/mc-100100579 · Cited by 237
SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.004 · Cited by 223
Sonawnae, A., Jena, Mohanty, Mallick, & Jacob (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28077 · Cited by 220
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro
Grenha, A., Grainger, C. I., Dailey, L. A., Seijo, B., Martin, G. P., Remuñán-López, C., & Forbes, B. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.008 · Cited by 219
Self-citationEvaluation of Differentiated Human Bronchial Epithelial Cell Culture Systems for Asthma Research
Stewart, C. E., Torr, E. E., Mohd Jamili, N. H., Bosquillon, C., & Sayers, I. (2012) · Journal of Allergy · doi:10.1155/2012/943982 · Cited by 215
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
Wang, Z. H., Wang, Z. Y., Sun, C. S., Wang, C. Y., Jiang, T. Y., & Wang, S. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.104 · Cited by 214
Zhang, C., Qu, G., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.029 · Cited by 205
Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells
Fattal, E., Mura, Nicolas, Hillaireau, H., Gueutin, Droumaguet, L., Zanna, & Tsapis (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24552 · Cited by 190
Zhang, X., Sun, M., Zheng, A., Cao, D., Bi, Y., & Sun, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.01.002 · Cited by 184
Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile
Nafee, N., Schneider, M., Schaefer, U. F., & Lehr, C.-M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.049 · Cited by 175
Keong, L. C., & Halim, A. S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031300 · Cited by 167
Chitosan-based systems for the delivery of vaccine antigens
Arca, H. Ç., Günbeyaz, M., & Şenel, S. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.47 · Cited by 165
Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems
Deacon, M., McGurk, S. L., Roberts, C. J., Williams, P. M., Tendler, S. J. B., Davies, M. C., Davis, S. S., & Harding, S. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480557 · Cited by 164
Sonaje, K., Lin, K., Tseng, M. T., Wey, S., Su, F.-Y., Chuang, E., Hsu, C.-W., Chen, C.-T., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.086 · Cited by 160
Uptake and cytotoxicity of chitosan nanoparticles in human liver cells
Loh, J. W., Yeoh, G. C., Saunders, M., & Lim, L. Y. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.029 · Cited by 149
Controlled Release Pulmonary Administration of Curcumin Using Swellable Biocompatible Microparticles
El-sherbiny, I. M., & Smyth, H. D. C. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200351y · Cited by 144
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800975j · Cited by 141
Soenen, S. J., & Cuyper, M. D. (2009) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.282 · Cited by 136
Zheng, F., Shi, X., Yang, G., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.040 · Cited by 131
The performance of nanocarriers for transmucosal drug delivery
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.463 · Cited by 127
Facilitated nanoscale delivery of insulin across intestinal membrane models
Woitiski, C. B., Sarmento, B. F. C. C., Carvalho, R. A., Neufeld, R. J., & Veiga, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.003 · Cited by 124
Scherließ, R. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.053 · Cited by 123
Zaki, N. M., & Hafez, M. M. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9758-7 · Cited by 122
Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications
Tan, W. B., & Zhang, Y. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30410 · Cited by 115
Relationship between physicochemical characteristics and functional properties of chitosan
Kofuji, K., Qian, C.-J., Nishimura, M., Sugiyama, I., Murata, Y., & Kawashima, S. (2005) · European Polymer Journal · doi:10.1016/j.eurpolymj.2005.04.041 · Cited by 114
Chopra, S., Mahdi, S., Kaur, J., Iqbal, Z., Talegaonkar, S., & Ahmad, F. J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0002 · Cited by 114
The Comet Assay: An Overview of Techniques
Olive, P. L. (2003) · Humana Press eBooks · doi:10.1385/1-59259-179-5:179 · Cited by 114
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers
Pandey, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh139 · Cited by 109
Semete, B., Booysen, L. I. J., Kalombo, L., Venter, J. D., Katata, L., Ramalapa, B., Verschoor, J. A., & Swai, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.002 · Cited by 108
Chitosan-Coated Solid Lipid Nanoparticles for Insulin Delivery
Fonte, P., Andrade, F., Araújo, F., Andrade, C., das Neves, J., & Sarmento, B. F. C. C. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00015-x · Cited by 106
Use of lactate dehydrogenase release to assess changes in culture viability
Racher, A. J., Looby, D., & Griffiths, J. B. (1990) · Cytotechnology · doi:10.1007/bf00365494 · Cited by 102
The potential of chitosan for the oral administration of peptides
Prego, C., Torres, D., & Alonso, M. J. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.843 · Cited by 102
Jeong, Y., Jin, S., Kim, I., Pei, J., Wen, M., Jung, T., Moon, K., & Jung, S. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.03.037 · Cited by 101
Lozano, M. V., Torrecilla, D., Torres, D., Vidal, A., Domínguez, F., & Alonso, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800298u · Cited by 100
Shu, S., Zhang, X., Teng, D., Wang, Z., & Li, C. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.04.018 · Cited by 95
Micro/Nanostructured Polymeric Systems for Biomedical and Pharmaceutical Applications
Chiellini, E., Piras, A. M., Errico, C., & Chiellini, E. (2008) · Nanomedicine · doi:10.2217/17435889.3.3.367 · Cited by 94
Preparation and biocompatibility of chitosan microcarriers as biomaterial
Chen, X. G., Liu, C., Liu, C., Meng, X., Lee, C. M., & Park, H.-J. (2005) · Biochemical Engineering Journal · doi:10.1016/j.bej.2005.08.021 · Cited by 94
Evaluation of Mucoadhesive PLGA Microparticles for Nasal Immunization
Pawar, D., Goyal, A. K., Mangal, S., Mishra, N., Vaidya, B., Tiwari, S., Jain, A., & Vyas, S. P. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9169-1 · Cited by 89
Kowapradit, J., Opanasopit, P., Ngawhirunpat, T., Apirakaramwong, A., Rojanarata, T., Ruktanonchai, U., & Sajomsang, W. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9399-7 · Cited by 84
Critical Role of Tight Junctions in Drug Delivery across Epithelial and Endothelial Cell Layers
González‐Mariscal, L., Nava, P., & Hernández, S. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0807-y · Cited by 81
Anitha, A., Chennazhi, K. P., Nair, S. V., & Jayakumar, R. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1365 · Cited by 79 · cited 1×
“Chitosan carriers have been frequently tested by means of the above mentioned assays, with a predominance of the MTT assay, not only using the original polymer [30,82–84], but also chitosan derivatives [85,86].”
MethodCytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells
Loh, J. W., Saunders, M., & Lim, L. Y. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.037 · Cited by 75
Molecular Aspects of Mucoadhesive Carrier Development for Drug Delivery and Improved Absorption
Peppas, N. A., Thomas, J. B., & McGinty, J. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208x393464 · Cited by 73
Portero, A., Remuñán‐López, C., & Nielsen, H. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1014220832384 · Cited by 72
The potential of chitosan for pulmonary drug delivery
Grenha, A., Al‐Qadi, S., Seijo, B., & Remuñán‐López, C. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50004-2 · Cited by 72
Self-citationPulmonary inflammation caused by chitosan microparticles
Huang, Y. C., Vieira, A. V., Huang, K. L., Yeh, M.-K., & Chiang, C. ‐. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30421 · Cited by 71
Fu, Q., Shin, H., Lee, B., & Han, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.007 · Cited by 68
Xu, J., Ma, L., Ma, L., Liu, Y., Xu, F., Nie, J., & Ma, G. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.12.034 · Cited by 64
Pokharkar, V., Dhar, S., Bhumkar, D. R., Mali, V., Bodhankar, S. L., & Prasad, B. L. V. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1027 · Cited by 58
Chitosan-graft-spermine as a gene carrier in vitro and in vivo
Jiang, H., Lim, H.-T., Kim, Y.-K., Arote, R. B., Shin, J., Kwon, J., Kim, J., Kim, J., Kim, D., Chae, C., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.014 · Cited by 50
Aden, P. K., Goverud, I. L., Liestøl, K., Løberg, E. M., Paulsen, R. E., Mæhlen, J., & Lømo, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.095 · Cited by 49
Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin
Sugihara, H., Yamamoto, H., Kawashimà, Y., & Takeuchi, H. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2011.621128 · Cited by 46
Potential applications of chitosan in oral mucosal delivery
Şenel, S. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50003-0 · Cited by 42
Discovery of tight junction modulators: significance for drug development and delivery
Johnson, P. H., Frank, D. E., & Costantino, H. R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.023 · Cited by 38
Choi, M., Cho, M., Han, B. S., Hong, J. T., Jeong, J., Park, S.-J., Cho, M., Kim, K., & Cho, W.-S. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.08.016 · Cited by 38
Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes
Fernandes, J. C., Borges, M. C., Nascimento, H., Bronze-da-Rocha, E., Ramos, Ó. L., Pintado, M., Malcata, F. X., & Santos‐Silva, A. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.05.032 · Cited by 31
Examination of cell–host–biomaterial interactions via high-throughput technologies: A re-appraisal
Power, K. A., Fitzgerald, K. T., & Gallagher, W. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.029 · Cited by 29
González‐Mariscal, L., Hernández, S., & Vega, J. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534117 · Cited by 28
Effect of Chitosan-Coated Alginate Microspheres on the Permeability of Caco-2 Cell Monolayers
Silva, C. M., Veiga, F., Ribeiro, A. J., Zerrouk, N., & Arnaud, P. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600735020 · Cited by 23
Cited by
Chitosan nanoparticle based delivery systems for sustainable agriculture
Kashyap, P. L., Xiang, X., & Heiden, P. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.02.039 · Cited by 813
Chitosan as biomaterial in drug delivery and tissue engineering
Ahsan, S. M., Thomas, M., Reddy, K. K., Sooraparaju, S. G., Asthana, A., & Bhatnagar, I. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.140 · Cited by 684
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Unsoy, G., Khodadust, R., Yalcin, S., Mutlu, P., & Gunduz, U. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.021 · Cited by 333
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles
Salatin, S., & Yari Khosroushahi, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13110 · Cited by 315
Metadata
- Authors
- Rodrigues, S., Dionísio, M., López, C. R., & Grenha, A.
- Venue
- Journal of Functional Biomaterials
- Publisher
- MDPI AG
- Published
- 2012-09-17
- Volume
- 3
- Issue
- 3
- Pages
- 615-641
- ISSN
- 2079-4983 (ISSN-L)
- OpenAlex
- W1976248881
- Cited by
- 389
- References
- 116
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.